Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice

Nephrology Dialysis Transplantation

Volumn 28, Issue 1, 2013, Pages 55-62

  Takamiya, Yoshimi ^a   Fukami, Kei ^a   Yamagishi, Sho Ichi ^a   Kaida, Yusuke ^a   Nakayama, Yosuke ^a   Obara, Nana ^a   Iwatani, Ryuji ^a   Ando, Ryotaro ^a   Koike, Kiyomi ^a   Matsui, Takanori ^a   Nishino, Yuri ^a   Ueda, Seiji ^a   Cooper, Mark E ^b   Okuda, Seiya ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

albuminuria; diabetic nephropathy; extracellular matrix; MMP 2; tubulointerstitial injury

Indexed keywords

ACETYLGLUCOSAMINIDASE; ALBUMIN; ALPHA SMOOTH MUSCLE ACTIN; CREATININE; GELATINASE A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; ENZYMURIA; EXTRACELLULAR MATRIX; GLOMERULUS; KIDNEY FIBROSIS; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; STREPTOZOCIN DIABETES; UREA NITROGEN BLOOD LEVEL;

ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84872247484     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs387     Document Type: Article

References (21)

1. Maisonneuve P, Agodoa L, Gellert R et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. Am J Kidney Dis 2000; 35: 157-165
2. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 1999; 56: 1627-1637
3. Mauer SM, Lane P, Hattori M et al. Renal structure and function in insulin-dependent diabetes mellitus and type I membranoproliferative glomerulonephritis in humans. J Am Soc Nephrol 1992; 2 (10 Suppl): S181-S184
4. Ha H, Lee HB. Reactive oxygen species and matrix remodeling in diabetic kidney. J Am Soc Nephrol 2003; 14 (8 Suppl 3): S246-S249
5. Han SY, Jee YH, Han KH et al. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy. Nephrol Dial Transplant 2006; 21: 2406-2416
6. Mason RM, Wahab NA. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 2003; 14: 1358-1373
7. Lenz O, Elliot SJ, Stetler-Stevenson WG. Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 2000; 11: 574-581
8. McLennan SV, Kelly DJ, Cox AJ et al. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia 2002; 45: 268-275
9. Del Prete D, Anglani F, Forino M et al. Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM. Diabetologia 1997; 40: 1449-1454
10. Itoh T, Ikeda T, Gomi H et al. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J Biol Chem 1997; 272: 22389-22392
11. Yamamoto S, Zuo Y, Ma J et al. Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice. Nephrol Dial Transplant 2011; 26: 2491-2497
12. Lassila M, Fukami K, Jandeleit-Dahm K et al. Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease. Diabetologia 2007; 50: 1315-1326
13. Woessner JF. Quantification of matrix metalloproteinases in tissue samples. Methods Enzymol 1995; 248: 510-528
14. Rauch BH, Bretschneider E, Braun M et al. Factor Xa releases matrix metalloproteinase-2 (MMP-2) from human vascular smooth muscle cells and stimulates the conversion of pro-MMP-2 to MMP-2: role of MMP-2 in factor Xa-induced DNA synthesis and matrix invasion. Circ Res 2002; 90: 1122-1127
15. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-839
16. Park IS, Kiyomoto H, Abboud SL et al. Expression of transforming growth factor-beta and type IV collagen in early streptozotocininduced diabetes. Diabetes 1997; 46: 473-480
17. Lassila M, Seah KK, Allen TJ et al. Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products. J Am Soc Nephrol 2004; 15: 2125-2138
18. Inada A, Nagai K, Arai H et al. Establishment of a diabetic mouse model with progressive diabetic nephropathy. Am J Pathol 2005; 167: 327-336
19. Birn H, Christensen EI. Renal albumin absorption in physiology and pathology. Kidney Int 2006; 69: 440-449
20. Lutz J, Yao Y, Song E et al. Inhibition of matrix metalloproteinases during chronic allograft nephropathy in rats. Transplantation 2005; 79: 655-661
21. Van Hul M, Lijnen HR. A functional role of gelatinase A in the development of nutritionally induced obesity in mice. J Thromb Haemost 2008; 6: 1198-1206